Inari, now part of Stryker

Built on a strong foundation of innovation, high-quality products and rigorous clinical evidence, Inari became one of the defining forces in venous care. Now, as Stryker’s Peripheral Vascular business, that foundation has everything it needs to go further.

We lead fearlessly, with a portfolio that spans the treatment of venous and arterial diseases. We innovate intentionally, designing technology alongside clinicians. And we transform together, expanding access, deepening expertise and raising the standard of care globally.

Introducing Stryker Peripheral Vascular. Purpose-built technology. Patient-centered solutions.

Follow us on LinkedIn: bit.ly/4tkdQ1T
Follow us on Instagram: bit.ly/4tvcT6i

#StrykerPV #PeripheralVascular #MedTech #SIR2026 #TogetherWithOurCustomers

The information in this post is intended for healthcare professionals in the United States only.

Our shared global commitment to our mission has enabled us to return to full operations across our manufacturing network. Patient care remains our highest priority, with a continued focus on supporting healthcare providers and the patients they serve.

Read more: stryker.com/us/en/about/ne…

March is Blood Clot Awareness Month!

Venous thromboembolism (#VTE)—including deep vein thrombosis (#DVT) and pulmonary embolism (#PE)—remains a significant clinical challenge across care settings. Early recognition, timely diagnosis, and informed treatment decisions play an important role in patient care.

Together, let’s raise awareness around blood clots and support continued education focused on improving outcomes for patients at risk of VTE.

#BloodClotAwarenessMonth #BCAM #VTE #PulmonaryEmbolism #DVT #TogetherWithOurCustomers #InariMedical

Review complete Instructions for Use, Indications for Use, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of the product.

The information in this post is intended for healthcare professionals in the United States only.

We're excited to be attending the 29th European Vascular Course (EVC) in Maastricht this March!

Join us for our hands-on workshop: "Don't let the clot settle: early intervention in acute DVT using AI and different clot removal techniques."

Monday 9 March 2026
14:00-15:30
Room 0.2

During this interactive session, Dr. Marie Josee van Rijn, Vascular Surgeon at Erasmus Medical Centre (Rotterdam), will share her real-world experience in:
- Patient selection for interventional treatment of acute #DVT
- Mechanisms and technical considerations of mechanical thrombectomy
- Acute DVT case studies and procedural strategy
- Latest clinical evidence and emerging insights

We look forward to connecting with peers and advancing the conversation on early intervention in DVT management.

See you in Maastricht!

#EVC2026 #Vascular #Thrombosis #MedicalInnovation #InterventionalRadiology

Review complete Instructions for Use, Indications for Use, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of the product.

The information in this post is intended for healthcare professionals only.

Stent surveillance does more than detect failure — it guides why failure occurs.

Patients with combined inflow disease had nearly 3× higher reintervention rates than those without inflow disease. Surveillance enables timely inflow assessment and targeted reintervention.

More on #RevCore: bit.ly/3BgcvTp

#RevCore #StentSurveillance #StentPatency #VenousIntervention

Review complete Instructions for Use, Indications for Use, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of the product.

The information in this post is intended for healthcare professionals in the United States only.